Skip to main content
Back to Mizuho Capital

Mizuho Capital's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by Mizuho Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$100.2M

Therapeutics Portfolio Companies (4)

Export
Addiction TreatmentHealth CareMedicalMobile AppsSoftwareTherapeutics

CureApp is a digital health and therapeutic medical device software that connects patients and doctors.

Tokyo, Japan
August 2022
$52.1M
Series G

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Tokyo, Japan
June 2026
$32.8M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingTherapeutics

Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

Minamimachi, Japan
April 2024
$7.6M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

30,000+ verified contacts

Explore Mizuho Capital's Full Portfolio

View all companies funded by Mizuho Capital across every industry and funding stage.

View Full Mizuho Capital Portfolio